We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$735M
AUM Growth
+$57.8M
Cap. Flow
+$11.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
31.1%
Holding
195
New
10
Increased
148
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$2.33M
2
AAPL icon
Apple
AAPL
+$1.25M
3
BE icon
Bloom Energy
BE
+$903K
4
MLPB icon
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
+$552K
5
CRM icon
Salesforce
CRM
+$365K

Top Sells

Rank Stock Value
1
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$2.15M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$601K
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$576K
4
GLUU
Glu Mobile Inc.
GLUU
+$503K
5
MRNA icon
Moderna
MRNA
+$495K

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 12.02%
3 Consumer Staples 10.97%
4 Financials 10.35%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BND icon
101
Vanguard Total Bond Market
BND
$157B
$497K 0.07%
5,789
+112
+2% +$9.55K
VEEV icon
102
Veeva Systems
VEEV
$33.1B
$495K 0.07%
1,593
+189
+13% +$52.7K
ACMR icon
103
ACM Research
ACMR
$5.42B
$490K 0.07%
14,391
+2,280
+19% +$62.6K
APPS icon
104
Digital Turbine
APPS
$975M
$490K 0.07%
6,449
+620
+11% +$44.2K
DXCM icon
105
DexCom
DXCM
$31.5B
$484K 0.07%
4,536
+472
+12% +$45.3K
AXON
106
Axon Enterprise
AXON
$42.5B
$482K 0.07%
2,725
+360
+15% +$53K
ALNY icon
107
Alnylam Pharmaceuticals
ALNY
$27.5B
$480K 0.07%
2,829
+402
+17% +$58.9K
BEAM icon
108
Beam Therapeutics
BEAM
$2.63B
$478K 0.07%
+3,712
New +$296K
FIVN icon
109
FIVE9
FIVN
$2.11B
$475K 0.06%
2,592
+289
+13% +$49.8K
ENPH icon
110
Enphase Energy
ENPH
$4.96B
$474K 0.06%
2,579
+457
+22% +$67K
XYZ
111
Block Inc
XYZ
$48.4B
$473K 0.06%
1,939
+176
+10% +$40.8K
FRPT icon
112
Freshpet
FRPT
$2.93B
$470K 0.06%
2,882
+248
+9% +$42.3K
ZS icon
113
Zscaler
ZS
$24.5B
$469K 0.06%
2,171
+275
+15% +$52.3K
WORK
114
DELISTED
Slack Technologies, Inc.
WORK
$469K 0.06%
10,597
+1,212
+13% +$51.9K
ZM icon
115
Zoom
ZM
$28.2B
$466K 0.06%
1,204
+174
+17% +$57.9K
NOW icon
116
ServiceNow
NOW
$115B
$463K 0.06%
4,215
+505
+14% +$51.2K
TTD icon
117
Trade Desk
TTD
$8.48B
$463K 0.06%
5,990
+760
+15% +$48.6K
AVLR
118
DELISTED
Avalara, Inc.
AVLR
$463K 0.06%
2,861
+380
+15% +$53K
TWLO icon
119
Twilio
TWLO
$30B
$461K 0.06%
1,169
+137
+13% +$47.6K
SMAR
120
DELISTED
Smartsheet Inc.
SMAR
$459K 0.06%
6,347
+904
+17% +$56.4K
EDIT icon
121
Editas Medicine
EDIT
$396M
$456K 0.06%
8,049
-377
-4% -$13.9K
BYND icon
122
Beyond Meat
BYND
$292M
$453K 0.06%
2,877
+431
+18% +$57.3K
ZNGA
123
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$453K 0.06%
42,606
+4,692
+12% +$49.4K
TWOU
124
DELISTED
2U Inc
TWOU
$450K 0.06%
360
+45
+14% +$51.9K
ATNX
125
DELISTED
Athenex, Inc. Common Stock
ATNX
$449K 0.06%
4,858
+2,698
+125% +$245K
3 4
5
6 7

Similar funds

AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.66% 1-Year Est. Return
AEPBI
AH Equity Partners Bio III Menlo Park, California $95M AUM 50.1% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

Spearhead Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Spearhead Capital Advisors held 195 positions worth $735M, up 8.5% from $677M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q2 2021 filing shows 10 new, 148 increased, 29 reduced and 4 closed positions. Its largest new stake was Golub Capital BDC: 150,000 shares worth $2.31M. The largest sale was Kiniksa Pharmaceuticals, an estimated $2.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q2 2021 buy was Golub Capital BDC: 150,000 shares worth $2.31M.
  • Spearhead Capital Advisors added most to Apple in Q2 2021, an estimated $1.25M increase.
  • Spearhead Capital Advisors's biggest Q2 2021 reduction was Kiniksa Pharmaceuticals, cutting an estimated $2.15M.
  • Spearhead Capital Advisors fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $576K.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $735M portfolio in Q2 2021.
  • Spearhead Capital Advisors opened 10 new positions and closed 4 in Q2 2021.
  • Spearhead Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $735M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.